| Lung Cancer |
1 |
1 |
| Biologic Therapy |
0 |
1 |
| Breast Cancer |
0 |
0.77 |
| Small Cell Lung Cancer |
0 |
0.73 |
| Antineoplastic Drug |
0 |
0.72 |
| Lung |
0 |
0.66 |
| Noncolorectal Gastrointestinal Cancer |
0 |
0.58 |
| Interstitial Lung Disease |
0 |
0.54 |
| Cancer |
0 |
0.51 |
| Gastric Cancer |
0 |
0.43 |
| Targeted Cancer Therapy |
0 |
0.41 |
| HER2-Positive Breast Cancer |
0 |
0.38 |
| Humanized Monoclonal Antibody |
0 |
0.36 |
| Tumor |
0 |
0.2 |
| Tobacco Cessation |
0 |
0.14 |
| Breast |
0 |
0.1 |
| Plasma |
0 |
0.1 |
| Prognosis |
0 |
0.1 |
| Smoking |
0 |
0.1 |
| Tissue |
0 |
0.1 |
| Business of Oncology |
0 |
0.05 |
| Europe |
0 |
0.05 |
| Face |
0 |
0.05 |
| Hospital |
0 |
0.05 |